









Markets
/
Stocks
/
nasdaq-ebs
/

Emergent BioSolutions Inc

EBS

View Detailed Chart

5.630USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

306.83MMarket Cap

LossP/E TTM



Emergent BioSolutions Inc

5.630

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

-4.08%

5 Days

-21.48%

1 Month

-19.46%

6 Months

-46.33%

Year to Date

-41.11%

1 Year

-44.31%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 3 analysts

HOLD

Current Rating

13.500

Target Price

139.79%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

173

Total

Median

Average

Company name

Ratings

Analysts

Emergent BioSolutions Inc

EBS

Biogen Inc

BIIB

Alnylam Pharmaceuticals Inc

ALNY

Vertex Pharmaceuticals Inc

VRTX

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(8)

Neutral(2)

Buy(0)

Indicators

Sell(2)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.403

Neutral

RSI(14)

33.595

Neutral

STOCH(KDJ)(9,3,3)

3.143

Oversold

ATR(14)

0.411

Low Volatility

CCI(14)

-178.144

Sell

Williams %R

99.773

Oversold

TRIX(12,20)

-0.039

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

6.172

Sell

MA10

6.726

Sell

MA20

6.910

Sell

MA50

6.657

Sell

MA100

5.962

Sell

MA200

7.586

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a Bioservices portfolio. Its segments include Commercial Products, MCM Products, and Services Segment. Commercial Products segment include NARCAN (naloxone HCl). MCM Products segment consists of its Anthrax - MCM, Smallpox - MCM and Other Products. Services segment consisting of its Bioservices offerings. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. Its portfolio of Bioservices consists of three but interrelated service pillars, such as development services (process and analytical development) and drug substance manufacturing.

Ticker SymbolEBS

CompanyEmergent BioSolutions Inc

CEOMr. Joseph C. (Joe) Papa

Websitehttps://emergentbiosolutions.com/